Neonatal Seizure Management: Is the Timing of Treatment Critical?

Andreea M Pavel1, Janet M Rennie2, Linda S de Vries3

  • 1INFANT Research Centre, Cork, Ireland; Department of Pediatrics and Child Health, University College Cork, Cork, Ireland.

Insights

Prompt treatment of neonatal seizures within one hour of onset significantly reduces seizure burden and frequency. This highlights the critical timing for effective intervention in newborns with electrographic seizures, emphasizing the need for improved diagnostic and treatment strategies.

Area of Science:

  • Neonatal Neurology
  • Clinical Neurophysiology
  • Pediatric Epilepsy Research

Background:

  • Neonatal seizures are a significant concern in newborns, requiring prompt diagnosis and management.
  • Electroencephalographic (EEG) monitoring is crucial for identifying electrographic seizures in neonates.
  • The optimal timing for initiating antiseizure medication (ASM) in neonatal seizures remains an area of active investigation.

Purpose of the Study:

  • To evaluate the impact of the time to treatment for the first electrographic seizure on subsequent seizure burden in neonates.
  • To describe the overall management of seizures in a large cohort of newborns undergoing EEG monitoring.
  • To investigate the relationship between early ASM administration and seizure outcomes in neonatal populations.

Main Methods:

  • A cohort of newborns (36-44 weeks gestation) from two European multicenter studies requiring EEG monitoring were analyzed.
  • Infants receiving ASM exclusively after electrographic seizure onset were categorized by treatment delay: within 1 hour, 1-2 hours, or >2 hours.
  • Key outcomes included seizure burden, maximum seizure burden, status epilepticus, seizure count, and ASM dosage within the first 24 hours post-seizure onset.

Main Results:

  • Out of 472 neonates, 154 (32.6%) had confirmed electrographic seizures.
  • Infants treated with ASM within 1 hour of seizure onset demonstrated significantly lower seizure burden (P=.029) and fewer seizures (P=.035) compared to later treatment groups.
  • Overall, 54.7% of infants received ASM, with variations in treatment timing and necessity observed.

Conclusions:

  • Early treatment of neonatal seizures, particularly within the first hour of electrographic onset, appears critical in reducing seizure burden.
  • The findings suggest that timely intervention may be a key factor in managing neonatal seizures effectively.
  • Further research is warranted to confirm the time-critical nature of neonatal seizure treatment and to improve diagnostic and therapeutic approaches.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
367
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
683
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
35
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
593
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
263